Active Ingredient History

  • Now
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a derivative of acetylsalicylic acid (ASA) in which a hydrogen atom on the benzene ring has been replaced by a trifluromethyl group. Trade names include Disgren, Grendis, Aflen and Triflux.   Wikipedia

  • SMILES: CC(=O)Oc1cc(ccc1C(=O)O)C(F)(F)F
  • Mol. Mass: 248.16
  • ALogP: 2.33
  • ChEMBL Molecule:
More Chemistry
2-acetoxy-4-trifluoromethylbenzoic acid | 2- (acetyloxy)-4-(trifluoromethyl)benzoic acid | disgren | triflusal


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue